These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27506543)

  • 1. Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts.
    Hammers DW; Sleeper MM; Forbes SC; Shima A; Walter GA; Sweeney HL
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27506543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microtubule-connexin-43 regulatory link suppresses arrhythmias and cardiac fibrosis in Duchenne muscular dystrophy mice.
    Himelman E; Nouet J; Lillo MA; Chong A; Zhou D; Wehrens XHT; Rodney GG; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H983-H995. PubMed ID: 36206047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
    Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
    Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.
    Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA
    Circ Res; 2014 Feb; 114(5):823-32. PubMed ID: 24449818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
    Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
    BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
    Kuno A; Tanno M; Horio Y
    Ann N Y Acad Sci; 2015 Aug; 1348(1):46-54. PubMed ID: 26109180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy.
    Lin BL; Shin JY; Jeffreys WP; Wang N; Lukban CA; Moorer MC; Velarde E; Hanselman OA; Kwon S; Kannan S; Riddle RC; Ward CW; Pullen SS; Filareto A; Kass DA
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36099033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
    Parvatiyar MS; Marshall JL; Nguyen RT; Jordan MC; Richardson VA; Roos KP; Crosbie-Watson RH
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.
    Betts CA; Saleh AF; Carr CA; Hammond SM; Coenen-Stass AM; Godfrey C; McClorey G; Varela MA; Roberts TC; Clarke K; Gait MJ; Wood MJ
    Sci Rep; 2015 Mar; 5():8986. PubMed ID: 25758104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in
    Gartz M; Haberman M; Prom MJ; Beatka MJ; Strande JL; Lawlor MW
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221088655. PubMed ID: 35353647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute AT
    Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
    J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.
    Nakamura A; Harrod GV; Davies KE
    Neuromuscul Disord; 2001 Apr; 11(3):251-9. PubMed ID: 11297940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.
    Meyers TA; Townsend D
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H303-15. PubMed ID: 25485898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
    Chun JL; O'Brien R; Berry SE
    Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
    Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.
    Bostick B; Shin JH; Yue Y; Wasala NB; Lai Y; Duan D
    J Mol Cell Cardiol; 2012 Aug; 53(2):217-22. PubMed ID: 22587991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
    Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.